Shareholders Equity: The sum of preferred and common equity items.
Legend Biotech Corporation Sponsored ADR (LEGN) had Shareholders Equity of $1.00B for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$1.03B |
|
$-296.80M |
|
$408.10M |
|
$620.80M |
|
$1.33B |
|
$-301.30M |
|
$18.70M |
|
$-282.60M |
|
$-282.60M |
|
$-296.80M |
|
$-296.80M |
|
$-296.80M |
|
$-296.80M |
|
$-301.30M |
|
$-272.40M |
|
184.32M |
|
184.32M |
|
$-1.62 |
|
$-1.62 |
|
| Balance Sheet Financials | |
$1.25B |
|
$116.30M |
|
$486.60M |
|
$1.73B |
|
$636.40M |
|
-- |
|
$95.20M |
|
$731.60M |
|
$1.00B |
|
$1.00B |
|
|
Shareholders Equity |
$1.00B |
184.94M |
|
| Cash Flow Statement Financials | |
$-100.20M |
|
$709.60M |
|
$-0.30M |
|
$286.70M |
|
$901.90M |
|
$615.20M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.96 |
|
-- |
|
-- |
|
-- |
|
0.32 |
|
60.34% |
|
-29.28% |
|
-29.28% |
|
-26.47% |
|
-27.47% |
|
-28.85% |
|
$-128.80M |
|
-- |
|
-- |
|
-- |
|
0.59 |
|
12.75 |
|
78.54 |
|
4.65 |
|
-29.62% |
|
-29.62% |
|
-17.12% |
|
-29.62% |
|
$5.42 |
|
$-0.70 |
|
$-0.54 |
|